<p>/PRNewswire/ -- 逸仙電商（&#34;逸仙&#34;或&#34;公司&#34;）（紐約證券交易所代碼：YSG），一家領先的中國美容集團，今天宣佈公司已與一個與 Trustar Capital 及公司創始人、董事會主席兼首席執行官黃金鋒先生相關的投資工具（&#34;買方&#34;）簽署了最終協議。根據該協議，買方將認購總額約為 1.2 億美元的人民幣計價可轉換高級票據，分為兩個相等的部分（&#34;第一票據&#34;和&#34;第二票據&#34;；合稱為&#34;票據&#34;），並附帶購買公司 A 類普通股的認股權證（&#34;認股權證&#34;）。黃先生作為個人投資者與 Trustar Capital 共同參與此次投資，彰顯了他對公司長期前景的強烈信心。</p>
<p>在滿足交割條件的情況下，預計第一票據將在 2026 年 3 月左右發行，第二票據預計將在今年晚些時候發行。該交易已獲得董事會及其審計委員會的審查和批准。公司計劃將票據發行的淨收益用於未來的產品研發（&#34;R&amp;D&#34;）、全球供應鏈整合、海外市場擴展、戰略併購（&#34;M&amp;A&#34;）及其他公司用途，以進一步推動公司的業務增長。</p>
<p>逸仙創始人、董事長兼首席執行官黃金鋒先生表示：&#34;此次投資彰顯了我對逸仙長期發展軌跡的堅定信心，以及我們團隊對執行戰略路線圖的堅定承諾。在動態的市場環境中，我們仍然致力於打造一個具有韌性的多品牌美容集團。我們非常高興能夠歡迎 Trustar Capital 的世界級資源和深厚行業專業知識。未來，我們將加強戰略合作伙伴關係，釋放新的協同效應，為我們的股東推動可持續增長和價值創造。&#34;</p>
<p>中信資本董事長兼首席執行官、Trustar Capital 董事長張毅辰先生也評論道：&#34;我們高度認可逸仙在戰略轉型方面的持續承諾，特別是在產品組合優化、組織提升和品牌建設方面的不懈努力，這為可持續增長奠定了堅實基礎。這項投資也反映了我們對黃金鋒先生及其管理團隊的深厚信心。他們具備卓越的全球視野，並在整合全球品牌資源方面展現了強大的能力。Trustar Capital 期待利用這一合作伙伴關係，支持逸仙通過跨境 M&amp;A 整合全球資源，加速其發展成為領先的全球美容集團。&#34;</p>
<p>除了資本支持，此次交易標誌着戰略聯盟的深化。Trustar Capital 將利用其廣泛的網絡，幫助逸仙在美容行業價值鏈中捕捉戰略協同效應。通過藉助 Trustar Capital 在跨境收購和併購後整合方面的成功經驗，逸仙旨在進一步推進其全球擴張戰略，鞏固其在全球美容市場的地位。</p>
<p><strong>票據和認股權證的條款</strong></p>
<p>票據的年利率為 1.5%，按半年支付。第一票據的初始到期日為自發行之日起 364 天，若公司收到來自中華人民共和國國家發展和改革委員會的外債登記證書（&#34;NDRC 證書&#34;），則將自動延長至五年。第二票據在滿足適用的交割條件（包括收到 NDRC 證書）後發行，將在第一票據發行日期的第五個週年到期。在第一票據發行日期後的初始 364 天內，票據可轉換為公司的 A 類普通股或美國存托股票（&#34;ADSs&#34;），每個 ADS 目前代表 20 股 A 類普通股，具體條款以票據為準。轉換價格為 4.63 美元，反映出在票據購買協議簽署日前五個連續交易日的 ADS 成交量加權平均價格基礎上溢價 20%。在每次交割時，公司還將發行認股權證，允許認股權證持有人以無現金方式購買與相應票據轉換後發行的 A 類普通股總數相等的十分之一的 A 類普通股，行使價格為每股 0.50 美元（相當於每 ADS 10.00 美元）。票據持有人有權要求公司在第一票據發行日期的第三個週年以現金回購全部或部分票據，回購價格反映 4% 的內部收益率（已支付的利息從應付金額中扣除）。公司還同意向買方授予與票據轉換後可發行的 A 類普通股及認股權證行使相關的某些登記權利。</p>
<p>本交易下證券的發行尚未註冊，並且根據 1933 年證券法（經修訂）免於註冊。本新聞稿不構成出售或招攬購買此處所述證券的要約，也不應在任何州或司法管轄區進行此類要約、招攬或銷售。</p>
<p><strong>關於 Trustar Capital</strong></p>
<p>Trustar Capital 是中信資本控股有限公司的私募股權子公司，專注於全球控制性收購機會，自成立以來已在中國、日本、美國、歐洲等地完成了超過 100 項投資。Trustar Capital 目前管理着 102 億美元的承諾資本。Trustar Capital 在美容行業擁有深厚的投資專業知識。其投資組合包括 Axilone，這是全球領先的主要美容包裝供應商之一，為眾多知名全球品牌提供服務。此外，Trustar Capital 在製藥和生物技術領域的廣泛佈局使其能夠為公司的前沿產品研發提供關鍵支持。Trustar Capital 還在推動數字化轉型方面擁有良好的業績記錄。</p>
<p>欲瞭解更多信息，請訪問 www.trustarcapital.com。</p>
<p><strong>關於逸仙控股有限公司</strong></p>
<p>逸仙控股有限公司（NYSE: YSG）是一家領先的中國美容集團，旨在成為全球美容創新的先鋒。公司成立於 2016 年，推出並收購了多個彩妝和護膚品牌，包括_完美日記_、<em>小奧汀</em>、<em>粉色熊</em>、<em>Galénic</em>、<em>DR.WU</em>（其中國大陸業務）和_Eve Lom_。</p>
<p>欲瞭解更多信息，請訪問 http://ir.yatsenglobal.com/。</p>
<p><strong>安全港聲明</strong></p>
<p>本公告包含可能構成 “前瞻性” 聲明的內容，這些聲明是根據 1995 年美國私人證券訴訟改革法案的 “安全港” 條款作出的。這些前瞻性聲明可以通過諸如 “將”、“期望”、“預期”、“旨在”、“未來”、“打算”、“計劃”、“相信”、“估計”、“可能” 等術語識別。公司還可能在其定期向證券交易委員會（“SEC”）提交的報告、年度股東報告、新聞稿和其他書面材料中，以及其高管、董事或員工向第三方作出的口頭聲明中，作出書面或口頭的前瞻性聲明。非歷史事實的聲明，包括關於公司信念、計劃、前景和期望的聲明，均為前瞻性聲明。前瞻性聲明涉及固有的風險和不確定性。一些因素可能導致實際結果與任何前瞻性聲明中包含的內容有實質性差異，包括但不限於以下因素：公司的增長戰略；其未來的業務發展、運營結果和財務狀況；其繼續推出受歡迎產品和維持現有產品受歡迎程度的能力；其及時預測和應對行業趨勢及消費者偏好和行為變化的能力；其吸引和留住新客户以及增加重複客户產生的收入的能力；其對產品和服務需求及市場接受度的預期；其整合新收購的業務和品牌的能力；與中國美容市場相關的趨勢、競爭及政府政策和法規；其收入及某些成本或費用項目的變化；以及全球及中國的整體經濟狀況。有關這些及其他風險的進一步信息包含在公司向 SEC 提交的文件中。本新聞稿中提供的所有信息均為本新聞稿發佈之日的信息，公司不承擔更新任何前瞻性聲明的義務，除非法律要求。</p>
<p><strong>如需投資者和媒體諮詢，請聯繫：</strong></p>
<p>逸仙控股有限公司</p>
<p>投資者關係</p>
<p>電子郵件：ir@yatsenglobal.com</p>
<p>來源：逸仙控股有限公司</p>

逸仙電商

<p>逸仙電商（Yatsen Holding Limited）宣佈進行一項人民幣計價的可轉換高級票據和認股權證的私募，金額約為 1.2 億美元。此次投資由 Trustar Capital 和公司的創始人兼首席執行官黃金鋒先生主導。資金將用於產品研發、全球供應鏈整合和戰略併購。該票據的利率為 1.5%，並可按溢價轉換為 A 類普通股。此次交易旨在增強逸仙在全球美容市場的地位，並提升其戰略合作伙伴關係</p>

<p>, /PRNewswire/ -- Yatsen Holding Limited (&#34;Yatsen&#34; or the &#34;Company&#34;) (NYSE: YSG), a leading China-based beauty group, today announced that the Company has entered into a definitive agreement with an investment vehicle (the &#34;Purchaser&#34;) affiliated with Trustar Capital and Mr. Jinfeng Huang, the Company's founder, Chairman of the Board of Directors (the &#34;Board&#34;) and Chief Executive Officer. Pursuant to the agreement, the Purchaser will subscribe for RMB-denominated convertible senior notes in an aggregate principal amount equivalent to approximately US$120 million, to be issued in two equal tranches (the &#34;First Note&#34; and the &#34;Second Note&#34;; together, the &#34;Notes&#34;), together with warrants to purchase Class A ordinary shares of the Company (the &#34;Warrants&#34;). Mr. Huang is participating in this investment on a personal basis alongside Trustar Capital as a co-investor through the Purchaser, underscoring his strong confidence in the Company's long-term prospects.</p>
<div class="lb-trans"><p>/PRNewswire/ -- 逸仙電商（&#34;逸仙&#34;或&#34;公司&#34;）（紐約證券交易所代碼：YSG），一家領先的中國美容集團，今天宣佈公司已與一個與 Trustar Capital 及公司創始人、董事會主席兼首席執行官黃金鋒先生相關的投資工具（&#34;買方&#34;）簽署了最終協議。根據該協議，買方將認購總額約為 1.2 億美元的人民幣計價可轉換高級票據，分為兩個相等的部分（&#34;第一票據&#34;和&#34;第二票據&#34;；合稱為&#34;票據&#34;），並附帶購買公司 A 類普通股的認股權證（&#34;認股權證&#34;）。黃先生作為個人投資者與 Trustar Capital 共同參與此次投資，彰顯了他對公司長期前景的強烈信心。</p>
</div><p>Subject to closing conditions, the First Note is expected to be issued in or around March 2026, and the Second Note is expected to be issued later this year. The transaction has been reviewed and approved by the Board and its audit committee. The Company plans to use the net proceeds from the issuance of the Notes for future product research and development (&#34;R&amp;D&#34;), global supply chain integration, overseas market expansion, and strategic mergers and acquisitions (&#34;M&amp;A&#34;), and other corporate purposes, to further drive the Company's business growth.</p>
<div class="lb-trans"><p>在滿足交割條件的情況下，預計第一票據將在 2026 年 3 月左右發行，第二票據預計將在今年晚些時候發行。該交易已獲得董事會及其審計委員會的審查和批准。公司計劃將票據發行的淨收益用於未來的產品研發（&#34;R&amp;D&#34;）、全球供應鏈整合、海外市場擴展、戰略併購（&#34;M&amp;A&#34;）及其他公司用途，以進一步推動公司的業務增長。</p>
</div><p>Mr. Jinfeng Huang, Founder, Chairman, and CEO of Yatsen, stated: &#34;This investment underscores my unwavering confidence in Yatsen's long-term trajectory and our team's firm commitment to executing our strategic roadmap. In the face of a dynamic market environment, we remain dedicated to building a resilient, multi-brand beauty group. We are thrilled to welcome Trustar Capital's world-class resources and deep industry expertise. Going forward, we will strengthen our strategic partnership to unlock new synergies, driving sustainable growth and value creation for our shareholders.&#34;</p>
<div class="lb-trans"><p>逸仙創始人、董事長兼首席執行官黃金鋒先生表示：&#34;此次投資彰顯了我對逸仙長期發展軌跡的堅定信心，以及我們團隊對執行戰略路線圖的堅定承諾。在動態的市場環境中，我們仍然致力於打造一個具有韌性的多品牌美容集團。我們非常高興能夠歡迎 Trustar Capital 的世界級資源和深厚行業專業知識。未來，我們將加強戰略合作伙伴關係，釋放新的協同效應，為我們的股東推動可持續增長和價值創造。&#34;</p>
</div><p>Mr. Yichen Zhang, Chairman and CEO of CITIC Capital and Chairman of Trustar Capital, also commented: &#34;We highly recognize Yatsen's continued commitment to its strategic transformation, particularly its relentless focus on product portfolio optimization, organizational enhancement, and brand building, which have established a solid foundation for sustainable growth. This investment also reflects our deep confidence in Mr. Jinfeng Huang and his management team. They possess an exceptional global vision and have demonstrated strong capability in integrating global brands resources. Trustar Capital looks forward to leveraging this partnership to support Yatsen in integrating global resources through cross-border M&amp;A, accelerating its evolution into a leading global beauty group.&#34;</p>
<div class="lb-trans"><p>中信資本董事長兼首席執行官、Trustar Capital 董事長張毅辰先生也評論道：&#34;我們高度認可逸仙在戰略轉型方面的持續承諾，特別是在產品組合優化、組織提升和品牌建設方面的不懈努力，這為可持續增長奠定了堅實基礎。這項投資也反映了我們對黃金鋒先生及其管理團隊的深厚信心。他們具備卓越的全球視野，並在整合全球品牌資源方面展現了強大的能力。Trustar Capital 期待利用這一合作伙伴關係，支持逸仙通過跨境 M&amp;A 整合全球資源，加速其發展成為領先的全球美容集團。&#34;</p>
</div><p>Beyond capital support, this transaction marks a deepening strategic alliance. Trustar Capital will leverage its extensive network to assist Yatsen in capturing strategic synergies across the beauty industry value chain. By drawing on Trustar Capital's proven track record in cross-border acquisitions and post-merger integration, Yatsen aims to further its global expansion strategy and solidify its position in the global beauty market.</p>
<div class="lb-trans"><p>除了資本支持，此次交易標誌着戰略聯盟的深化。Trustar Capital 將利用其廣泛的網絡，幫助逸仙在美容行業價值鏈中捕捉戰略協同效應。通過藉助 Trustar Capital 在跨境收購和併購後整合方面的成功經驗，逸仙旨在進一步推進其全球擴張戰略，鞏固其在全球美容市場的地位。</p>
</div><p><strong>Terms of the Notes and the Warrants</strong></p>
<div class="lb-trans"><p><strong>票據和認股權證的條款</strong></p>
</div><p>The Notes will bear interest at a rate of 1.5% per annum, payable semi-annually. The First Note has an initial maturity of 364 days from issuance, which will automatically extend to five years upon the Company's receipt of a foreign debt registration certificate from the National Development and Reform Commission of the People's Republic of China (the &#34;NDRC Certificate&#34;). The Second Note, if issued following the satisfaction of the applicable closing conditions (including receipt of the NDRC Certificate), will mature on the fifth anniversary of the issue date of the First Note. Following an initial period of 364 days from the issue date of the First Note, the Notes may be converted into the Company's Class A ordinary shares or American depositary shares (&#34;ADSs&#34;), each currently representing twenty Class A ordinary shares, subject to the terms of the Notes. The conversion price is $4.63, reflecting a premium of 20% above the volume weighted average price of the ADSs for the five consecutive trading days prior to, and including, the trading day immediately preceding the date of the note purchase agreement. At each closing, the Company will also issue the Warrants entitling the Warrant holder to acquire, on a cashless basis, a number of Class A ordinary shares equal in the aggregate to one-tenth of the Class A ordinary shares issued upon conversion of the corresponding Note, at an exercise price of US$0.50 per Class A ordinary share (equivalent to US$10.00 per ADS). Holders of the Notes have the right to require the Company to repurchase all or part of the Notes for cash on the third anniversary of the issue date of the First Note at a repurchase price reflecting a 4% internal rate of return (with any interests already paid deducted from the amount payable). The Company has also agreed to grant the Purchaser certain registration rights with respect to the Class A ordinary shares issuable upon conversion of the Notes and exercise of the Warrants.</p>
<div class="lb-trans"><p>票據的年利率為 1.5%，按半年支付。第一票據的初始到期日為自發行之日起 364 天，若公司收到來自中華人民共和國國家發展和改革委員會的外債登記證書（&#34;NDRC 證書&#34;），則將自動延長至五年。第二票據在滿足適用的交割條件（包括收到 NDRC 證書）後發行，將在第一票據發行日期的第五個週年到期。在第一票據發行日期後的初始 364 天內，票據可轉換為公司的 A 類普通股或美國存托股票（&#34;ADSs&#34;），每個 ADS 目前代表 20 股 A 類普通股，具體條款以票據為準。轉換價格為 4.63 美元，反映出在票據購買協議簽署日前五個連續交易日的 ADS 成交量加權平均價格基礎上溢價 20%。在每次交割時，公司還將發行認股權證，允許認股權證持有人以無現金方式購買與相應票據轉換後發行的 A 類普通股總數相等的十分之一的 A 類普通股，行使價格為每股 0.50 美元（相當於每 ADS 10.00 美元）。票據持有人有權要求公司在第一票據發行日期的第三個週年以現金回購全部或部分票據，回購價格反映 4% 的內部收益率（已支付的利息從應付金額中扣除）。公司還同意向買方授予與票據轉換後可發行的 A 類普通股及認股權證行使相關的某些登記權利。</p>
</div><p>The issuance of the securities under this transaction has not been registered and is exempt from registration under the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.</p>
<div class="lb-trans"><p>本交易下證券的發行尚未註冊，並且根據 1933 年證券法（經修訂）免於註冊。本新聞稿不構成出售或招攬購買此處所述證券的要約，也不應在任何州或司法管轄區進行此類要約、招攬或銷售。</p>
</div><p><strong>About Trustar Capital</strong></p>
<div class="lb-trans"><p><strong>關於 Trustar Capital</strong></p>
</div><p>Trustar Capital, the private equity affiliate of CITIC Capital Holdings Limited, focuses on control buyout opportunities globally and has completed over 100 investments since inception across China, Japan, U.S., Europe, etc. Trustar Capital currently manages US$10.2 billion of committed capital. Trustar Capital possesses profound investment expertise within the beauty industry. Its portfolio includes Axilone, one of the world's leading primary beauty packaging providers, which serves many prestigious global brands. Furthermore, Trustar Capital's extensive footprint in the pharmaceutical and biotechnology sectors positions it to provide critical support for the Company's cutting-edge product R&amp;D. Trustar Capital also brings a proven track record in driving digital transformation.</p>
<div class="lb-trans"><p>Trustar Capital 是中信資本控股有限公司的私募股權子公司，專注於全球控制性收購機會，自成立以來已在中國、日本、美國、歐洲等地完成了超過 100 項投資。Trustar Capital 目前管理着 102 億美元的承諾資本。Trustar Capital 在美容行業擁有深厚的投資專業知識。其投資組合包括 Axilone，這是全球領先的主要美容包裝供應商之一，為眾多知名全球品牌提供服務。此外，Trustar Capital 在製藥和生物技術領域的廣泛佈局使其能夠為公司的前沿產品研發提供關鍵支持。Trustar Capital 還在推動數字化轉型方面擁有良好的業績記錄。</p>
</div><p>For more information, please visit www.trustarcapital.com.</p>
<div class="lb-trans"><p>欲瞭解更多信息，請訪問 www.trustarcapital.com。</p>
</div><p><strong>About Yatsen Holding Limited</strong></p>
<div class="lb-trans"><p><strong>關於逸仙控股有限公司</strong></p>
</div><p>Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including <em>Perfect Diary</em>, <em>Little Ondine</em>, <em>Pink Bear</em>, <em>Galénic</em>, <em>DR.WU</em> (its mainland China business), and <em>Eve Lom</em>.</p>
<div class="lb-trans"><p>逸仙控股有限公司（NYSE: YSG）是一家領先的中國美容集團，旨在成為全球美容創新的先鋒。公司成立於 2016 年，推出並收購了多個彩妝和護膚品牌，包括_完美日記_、<em>小奧汀</em>、<em>粉色熊</em>、<em>Galénic</em>、<em>DR.WU</em>（其中國大陸業務）和_Eve Lom_。</p>
</div><p>For more information, please visit http://ir.yatsenglobal.com/.</p>
<div class="lb-trans"><p>欲瞭解更多信息，請訪問 http://ir.yatsenglobal.com/。</p>
</div><p><strong>Safe Harbor Statement</strong></p>
<div class="lb-trans"><p><strong>安全港聲明</strong></p>
</div><p>This announcement contains statements that may constitute &#34;forward-looking&#34; statements which are made pursuant to the &#34;safe harbor&#34; provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as &#34;will,&#34; &#34;expects,&#34; &#34;anticipates,&#34; &#34;aims,&#34; &#34;future,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;believes,&#34; &#34;estimates,&#34; &#34;likely to,&#34; and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (&#34;SEC&#34;), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.</p>
<div class="lb-trans"><p>本公告包含可能構成 “前瞻性” 聲明的內容，這些聲明是根據 1995 年美國私人證券訴訟改革法案的 “安全港” 條款作出的。這些前瞻性聲明可以通過諸如 “將”、“期望”、“預期”、“旨在”、“未來”、“打算”、“計劃”、“相信”、“估計”、“可能” 等術語識別。公司還可能在其定期向證券交易委員會（“SEC”）提交的報告、年度股東報告、新聞稿和其他書面材料中，以及其高管、董事或員工向第三方作出的口頭聲明中，作出書面或口頭的前瞻性聲明。非歷史事實的聲明，包括關於公司信念、計劃、前景和期望的聲明，均為前瞻性聲明。前瞻性聲明涉及固有的風險和不確定性。一些因素可能導致實際結果與任何前瞻性聲明中包含的內容有實質性差異，包括但不限於以下因素：公司的增長戰略；其未來的業務發展、運營結果和財務狀況；其繼續推出受歡迎產品和維持現有產品受歡迎程度的能力；其及時預測和應對行業趨勢及消費者偏好和行為變化的能力；其吸引和留住新客户以及增加重複客户產生的收入的能力；其對產品和服務需求及市場接受度的預期；其整合新收購的業務和品牌的能力；與中國美容市場相關的趨勢、競爭及政府政策和法規；其收入及某些成本或費用項目的變化；以及全球及中國的整體經濟狀況。有關這些及其他風險的進一步信息包含在公司向 SEC 提交的文件中。本新聞稿中提供的所有信息均為本新聞稿發佈之日的信息，公司不承擔更新任何前瞻性聲明的義務，除非法律要求。</p>
</div><p><strong>For investor and media inquiries, please contact:</strong></p>
<div class="lb-trans"><p><strong>如需投資者和媒體諮詢，請聯繫：</strong></p>
</div><p>Yatsen Holding Limited</p>
<div class="lb-trans"><p>逸仙控股有限公司</p>
</div><p>Investor Relations</p>
<div class="lb-trans"><p>投資者關係</p>
</div><p>E-mail: ir@yatsenglobal.com</p>
<div class="lb-trans"><p>電子郵件：ir@yatsenglobal.com</p>
</div><p>SOURCE Yatsen Holding Limited</p>
<div class="lb-trans"><p>來源：逸仙控股有限公司</p>
</div>

Yatsen Announces Private Placement of Convertible Notes and Warrants | YSG Stock News

- Yatsen Holding 與 Trustar Capital 達成投資協議，融資約 1.2 億美元。  
- 資金將用於產品研發、市場擴展及戰略收購。  
- 黃錦鋒對公司長期發展表示強信心，交易預計將於 2026 年 3 月完成。

逸仙電商宣佈進行可轉換債券和認股權證的私募發行 | YSG 股票新聞